“This is a disaster,” the specialist said. “People are going to start dying. As a matter a fact, they started dying already.”

How does COVID-19 impact most athletes? When should clinicians turn to cardiac imaging? A team of specialists discussed these topics, and more, in JAMA Cardiology. 

“If our finding is confirmed, it would make aspirin the first widely available, over-the-counter medication to reduce mortality in COVID-19 patients," one researcher observed. 

The analysis, published in JAMA Network Open, included data from nearly 1.8 million Medicare patients. 

The research, published in Circulation, focused on the combination of pharmacologic therapy and the temporary use of a left ventricular assist device.

The increasingly popular ketogenic diet could be a valuable tool in the fight against heart failure, according to a new study published in Nature Metabolism.

Prior studies focused on myocardial injury had not included much, if any, insight into medical imaging data, making the results less helpful to clinicians.

The meta-analysis, published in the American Journal of Cardiology, explored data from six different randomized trials. 

Elevated EPA and ALA levels were associated with better outcomes for STEMI patients, including fewer cardiovascular complications and improved survival. 

World Stroke Day is on the horizon, and the American Stroke Association is highlighting the potential power of prevention.